TEAD1 and c-Cbl are novel prostate basal cell markers that correlate with poor clinical outcome in prostate cancer

Prostate cancer is the most frequently diagnosed male cancer, and its clinical outcome is difficult to predict. The disease may involve the inappropriate expression of genes that normally control the proliferation of epithelial cells in the basal layer and their differentiation into luminal cells. O...

Descripción completa

Detalles Bibliográficos
Autores principales: Knight, J F, Shepherd, C J, Rizzo, S, Brewer, D, Jhavar, S, Dodson, A R, Cooper, C S, Eeles, R, Falconer, A, Kovacs, G, Garrett, M D, Norman, A R, Shipley, J, Hudson, D L
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2008
Materias:
Molecular Diagnostics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2600693/
https://www.ncbi.nlm.nih.gov/pubmed/19002168
http://dx.doi.org/10.1038/sj.bjc.6604774

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2600693/
https://www.ncbi.nlm.nih.gov/pubmed/19002168
http://dx.doi.org/10.1038/sj.bjc.6604774

Ejemplares similares